News from bausch lomb A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 24, 2013, 08:00 ET

Soccer star Kaylyn Kyle talks performance with Canada's soccer moms

Focus on Performance campaign helps moms guide their children to soccer greatness TORONTO, July 24, 2013 /CNW/ - The summer season means that...

Jul 18, 2013, 08:00 ET

Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES)

 Bausch + Lomb, the global eye health company, and Mimetogen Pharmaceuticals Inc. today announced that Bausch + Lomb has acquired an option to...

Jun 20, 2013, 08:00 ET
Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.  We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.  (PRNewsFoto/Bausch + Lomb)

New Review Finds That Many Americans Over Age 50 are Not Getting Enough of Key Nutrients in Their Daily Diet to Support Their Eye Health

 A recent review published as an Expert Opinion in the Journal of Clinical Interventions in Aging outlines the link between specific nutrients...

Jun 18, 2013, 10:00 ET
Americans report being left high and dry while on computers, in front of TVs and on the road.  (PRNewsFoto/Bausch + Lomb)

Americans Report Being Left High and Dry While On Computers, In Front of TVs and On the Road

 Fact: the average person spends more than 33 hours per week watching TV.1 Add in the average 3.6 hours per day in front of a screen...

May 28, 2013, 10:57 ET
Valeant Pharmaceuticals International, Inc. Logo.  (PRNewsFoto/Bausch + Lomb)

Valeant Pharmaceuticals International, Inc. adquirirá Bausch + Lomb por US$8.700 millones

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) y Bausch + Lomb Holdings Incorporated, la compañía global de salud...

May 28, 2013, 10:34 ET
Valeant Pharmaceuticals International, Inc. Logo.  (PRNewsFoto/Bausch + Lomb)

Valeant Pharmaceuticals International, Inc. vai comprar a Bausch + Lomb por US$8,7 bilhões

- Vai tornar a Valeant a líder mundial em saúde ocular, assim como em dermatologia - Expectativa do alcance de uma economia de custo...

May 28, 2013, 07:45 ET
Valeant Pharmaceuticals International, Inc. Logo.  (PRNewsFoto/Bausch + Lomb)

Valeant Pharmaceuticals International, Inc. übernimmt Bausch + Lomb für $ 8,7 Milliarden

- Valeant wird damit zu einem der Weltmarkführer bei Augengesundheit und Dermatologie - Erwartete jährliche Kosteneinsparungen von...

May 27, 2013, 21:29 ET
Valeant Pharmaceuticals International, Inc. Logo.  (PRNewsFoto/Bausch + Lomb)

Valeant Pharmaceuticals International, Inc. s'apprête à acquérir Bausch + Lomb pour 8,7 milliards $

- Une transaction qui devrait positionner Valeant en tant que leader mondial à la fois en matière de santé oculaire et de...

May 27, 2013, 15:24 ET
Valeant Pharmaceuticals International, Inc. Logo.  (PRNewsFoto/Bausch + Lomb)

Valeant Pharmaceuticals International, Inc. adquirirá Bausch + Lomb por 8.700 millones de dólares

- Establecerá Valeant como un líder global en salud ocular así como en dermatología - Se espera que alcance un ahorro en...

May 27, 2013, 08:00 ET
Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.  We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.  (PRNewsFoto/Bausch + Lomb)

Valeant Pharmaceuticals International, Inc. To Acquire Bausch + Lomb For $8.7 Billion

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Bausch + Lomb Holdings Incorporated, the global eye health company,...

May 24, 2013, 14:56 ET

Bausch + Lomb Announces Settlement with the U.S. Department of Justice to Resolve and Conclude ISTA Pharmaceuticals Investigation

Bausch + Lomb, the global eye health company, announced today its subsidiary, ISTA Pharmaceuticals, Inc., a corporation that it acquired in June...

May 21, 2013, 10:00 ET

Bausch + Lomb Receives FDA Approval for the TRULIGN™ Toric Posterior Chamber Intraocular Lens

 Bausch + Lomb, the global eye health company, today announced that it is has received approval from the U.S. Food and Drug...

May 15, 2013, 17:06 ET

Maria Teresa Hilado neues Vorstandsmitglied bei Bausch + Lomb

Bausch + Lomb, weltweit tätiges Unternehmen für die Augengesundheit, gab heute bekannt, dass Maria Teresa (Tessa) Hilado in den Vorstand...

May 15, 2013, 13:50 ET
Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.  We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.  (PRNewsFoto/Bausch + Lomb)

Maria Teresa Hilado rejoint le Conseil d'administration de Bausch + Lomb

Bausch + Lomb, société mondiale de soins oculaires, a annoncé aujourd'hui l'élection de Maria Teresa (Tessa) Hilado au Conseil...

May 15, 2013, 13:44 ET
Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.  We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.  (PRNewsFoto/Bausch + Lomb)

Maria Teresa Hilado se une a la junta directiva de Bausch + Lomb

Bausch + Lomb, la compañía mundial de salud ocular, ha anunciado que Maria Teresa (Tessa) Hilado ha sido elegida para su junta...

May 15, 2013, 08:00 ET

María Teresa Hilado se incorpora al directorio de Bausch + Lomb

Bausch + Lomb, la compañía global de salud ocular, anunció hoy que María Teresa (Tessa) Hilado fue elegida como miembro de su...

May 15, 2013, 08:00 ET
Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.  We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.  (PRNewsFoto/Bausch + Lomb)

Maria Teresa Hilado integra o Conselho Diretor da Bausch + Lomb

A Bausch + Lomb, a empresa global da saúde dos olhos, anunciou hoje que Maria Teresa (Tessa) Hilado foi escolhida para integrar seu Conselho...

May 15, 2013, 08:00 ET

Maria Teresa Hilado Joins Bausch + Lomb Board of Directors

Bausch + Lomb, the global eye health company, today announced that Maria Teresa (Tessa) Hilado has been elected to its board of directors. Ms....

May 09, 2013, 07:30 ET
Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people's eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.  We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide.  (PRNewsFoto/Bausch + Lomb)

Alex Kelly Joins Bausch + Lomb as Vice President Investor Relations

Bausch + Lomb, the global eye health company, today announced that Alex Kelly has joined the company as vice president, Investor Relations,...

May 06, 2013, 13:48 ET
PhysIOL Ankoris hydrophilic acrylic intraocular lens (IOL).  (PRNewsFoto/Bausch + Lomb)

Bausch + Lomb gaat trifocale diffractieve en torische intraoculaire lenzen van PhysIOL verdelen op belangrijke Aziatische, Europese en Midden-Oosterse markten

-- Hydrofiel lensaanbod versterkt en vergroot oogheelkundige chirurgie portfolio van Bausch + Lomb Bausch + Lomb, het wereldwijde...